Healthcare Sector

Members of Parliament invested in the Healthcare Sector

149 investments

71 companies

Investors

Filed	Name	Company	Pur. £	Cur. £	P/L %	MPV*
Feb '17	Lord Arbuthnot of Edrom	Neuro-bio / NMS:NBIX	£43.24	£127.31	194.43%	£206,098.51
Apr '16	Baroness Greenfield	Neuro-bio / NMS:NBIX	£46.13	£127.31	175.98%	£193,186.64
Apr '24	Lord Balfe	Astrazeneca / LSE:AZN.L	£12,024.00	£10,552.00	-12.24%	£61,430.47
Dec '16	Lord Burns	Astrazeneca / LSE:AZN.L	£4,116.00	£10,552.00	156.37%	£179,455.78
May '20	Lord Deighton	Astrazeneca / LSE:AZN.L	£8,361.00	£11,236.00	34.39%	£94,070.09**
Mar '14	Viscount Eccles	Astrazeneca / LSE:AZN.L	£3,876.50	£10,552.00	172.20%	£190,543.02
Feb '21	Lord Etherton	Astrazeneca / LSE:AZN.L	£7,422.00	£10,552.00	42.17%	£99,520.34
May '23	Lord Fink	Astrazeneca / LSE:AZN.L	£11,774.00	£10,552.00	-10.38%	£62,734.84
Sep '16	Lord Gadhia	Astrazeneca / LSE:AZN.L	£5,099.00	£10,024.00	96.59%	£137,611.30**
Apr '12	Lord Glendonbrook	Astrazeneca / LSE:AZN.L	£2,666.50	£10,552.00	295.72%	£277,007.31
May '24	Lord Goldsmith	Astrazeneca / LSE:AZN.L	£12,156.00	£10,552.00	-13.20%	£60,763.41
May '18	Lord Grabiner	Astrazeneca / LSE:AZN.L	£5,417.00	£10,552.00	94.79%	£136,355.92
May '23	Lord Leitch	Astrazeneca / LSE:AZN.L	£11,820.00	£12,340.00	4.40%	£73,079.53**
May '23	Lord Londesborough	Astrazeneca / LSE:AZN.L	£11,924.00	£10,552.00	-11.51%	£61,945.66
Nov '23	Lord Mance	Astrazeneca / LSE:AZN.L	£10,230.00	£10,552.00	3.15%	£72,203.32
Jun '21	Lord Morse	Astrazeneca / LSE:AZN.L	£8,005.00	£10,552.00	31.82%	£92,272.33
Apr '10	Baroness Noakes	Astrazeneca / LSE:AZN.L	£2,938.00	£10,552.00	259.16%	£251,409.12
Dec '23	Lord Browne of Madingley	Allurion / NYQ:ALUR	£3.31	£2.42	-26.89%	£51,178.25
Dec '16	Lord Burns	Glaxosmithkline / NYQ:GSK	£37.39	£38.64	3.34%	£72,340.20
Mar '14	Baroness Eccles of Moulton	Glaxosmithkline / NYQ:GSK	£53.43	£38.64	-27.68%	£50,623.24
Apr '21	Lord Farmer	Glaxosmithkline / NYQ:GSK	£36.65	£40.88	11.54%	£78,079.12**
Jan '20	Lord Gadhia	Glaxosmithkline / NYQ:GSK	£46.50	£40.95	-11.94%	£61,645.16**
May '11	Lord Glendonbrook	Glaxosmithkline / NYQ:GSK	£42.78	£38.64	-9.68%	£63,225.81
Apr '10	Lord Levene of Portsoken	Glaxosmithkline / NYQ:GSK	£39.38	£38.64	-1.88%	£68,684.61
Mar '17	Lord Lloyd-Webber	Glaxosmithkline / NYQ:GSK	£42.31	£38.64	-8.67%	£63,928.15
Apr '10	Baroness Noakes	Glaxosmithkline / NYQ:GSK	£39.49	£38.64	-2.15%	£68,493.28
Jan '13	Lord Sassoon	Glaxosmithkline / NYQ:GSK	£44.75	£38.64	-13.65%	£60,442.46
Oct '20	Lord Taverne	Glaxosmithkline / NYQ:GSK	£37.57	£40.95	9.00%	£76,297.58**
May '24	Lord Balfe	Glaxosmithkline / NYQ:GSK	£44.02	£38.64	-12.22%	£61,444.80
May '25	Lord Hayward	Glaxosmithkline / NYQ:GSK	£37.37	£38.64	3.40%	£72,378.91
Aug '14	Lord Carter of Coles	Johnson & Johnson / NYQ:JNJ	£100.16	£161.55	61.29%	£112,904.35**
Apr '22	Lord Cromwell	Johnson & Johnson / NYQ:JNJ	£179.90	£154.37	-14.19%	£60,066.15**
May '23	Lord Fink	Johnson & Johnson / NYQ:JNJ	£165.03	£150.73	-8.67%	£63,934.43
Jul '16	Lord Lloyd-Webber	Johnson & Johnson / NYQ:JNJ	£122.64	£150.73	22.90%	£86,033.10
Jan '13	Lord Sassoon	Johnson & Johnson / NYQ:JNJ	£72.69	£150.73	107.36%	£145,152.01
Aug '17	Lord Sterling of Plaistow	Johnson & Johnson / NYQ:JNJ	£133.45	£157.98	18.38%	£82,866.99**
Feb '11	Lord Wasserman	Johnson & Johnson / NYQ:JNJ	£60.93	£150.73	147.38%	£173,167.56
Mar '25	Lord Fink	Johnson & Johnson / NYQ:JNJ	£161.72	£150.73	-6.80%	£65,243.01
Aug '18	Lord Carter of Coles	Danaher / NYQ:DHR	£90.94	£194.44	113.81%	£149,668.39
Apr '22	Lord Cromwell	Danaher / NYQ:DHR	£245.55	£201.40	-17.98%	£57,414.25**
Jul '16	Lord Glendonbrook	Danaher / NYQ:DHR	£72.15	£194.44	169.48%	£188,634.74
Apr '22	Lord Grabiner	Danaher / NYQ:DHR	£248.88	£194.44	-21.87%	£54,687.55
Aug '17	Lord Sterling of Plaistow	Danaher / NYQ:DHR	£71.88	£212.78	196.02%	£207,216.44**
Jul '18	Lord Carter of Coles	Essilor International / VIE:EI.VI	£126.10	£240.60	90.80%	£133,560.67
Aug '18	Lord Carter of Coles	Unitedhealth Group / NYQ:UNH	£253.22	£307.20	21.32%	£84,922.21
Jan '23	Lord Goldsmith	Unitedhealth Group / NYQ:UNH	£490.06	£307.20	-37.31%	£43,880.34
Nov '23	Lord Mance	Unitedhealth Group / NYQ:UNH	£537.83	£307.20	-42.88%	£39,982.89
Jan '18	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£221.16	£380.64	72.11%	£120,477.48**
Mar '25	Lord Fink	Unitedhealth Group / NYQ:UNH	£518.20	£307.20	-40.72%	£41,497.49
Apr '25	Lord Grabiner	Unitedhealth Group / NYQ:UNH	£594.40	£307.20	-48.32%	£36,177.66
Feb '19	Lord Carter of Coles	Mettler Toledo / NYQ:MTD	£672.49	£1,145.47	70.33%	£119,232.85
May '19	Lord Sterling of Plaistow	Mettler Toledo / NYQ:MTD	£701.77	£1,481.07	111.05%	£147,733.44**
Sep '20	Lord Carter of Coles	Thermo Fisher Scientific / NYQ:TMO	£418.14	£392.56	-6.12%	£65,717.70
Apr '22	Lord Grabiner	Thermo Fisher Scientific / NYQ:TMO	£570.94	£438.15	-23.26%	£53,719.30**
May '18	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£215.97	£423.55	96.12%	£137,280.64**
Nov '23	Lord Mance	Thermo Fisher Scientific / NYQ:TMO	£459.24	£392.56	-14.52%	£59,836.25
Aug '20	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£416.17	£403.13	-3.13%	£67,806.66**
Jan '25	Lord Sassoon	Thermo Fisher Scientific / NYQ:TMO	£583.64	£392.56	-32.74%	£47,082.45
Sep '21	Lord Darzi of Denham	Oxford Nanopore / LSE:ONT.L	£612.60	£118.50	-80.66%	£13,540.65
Apr '22	Lord Spencer of Alresford	Oxford Nanopore / LSE:ONT.L	£320.00	£118.50	-62.97%	£25,921.88
Apr '21	Baroness Deech	Novo Nordisk As / NYQ:NVO	£36.35	£74.01	103.60%	£142,522.71
Apr '24	Lord Grabiner	Novo Nordisk As / NYQ:NVO	£127.46	£64.73	-49.22%	£35,549.19**
Nov '23	Lord Mance	Novo Nordisk As / NYQ:NVO	£101.69	£74.01	-27.22%	£50,946.01
May '22	Lord Reay	Novo Nordisk As / NYQ:NVO	£56.40	£140.80	149.67%	£174,767.27**
Nov '21	Lord Sherbourne of Didsbury	Novo Nordisk As / NYQ:NVO	£56.71	£74.01	30.52%	£91,362.31
Apr '24	Lord Willoughby de Broke	Novo Nordisk As / NYQ:NVO	£122.75	£74.01	-39.71%	£42,205.30
May '24	Lord Londesborough	Novo Nordisk As / NYQ:NVO	£134.66	£74.01	-45.04%	£38,472.45
Apr '21	Baroness Deech	Zoetis / NYQ:ZTS	£168.10	£155.06	-7.76%	£64,569.90
Mar '25	Lord Fink	Zoetis / NYQ:ZTS	£162.82	£155.06	-4.77%	£66,663.80
Apr '21	Baroness Deech	Novartis / NYQ:NVS	£88.38	£115.96	31.21%	£91,844.31
Apr '17	Lord Donoughue	Novartis / NYQ:NVS	£66.05	£115.96	75.57%	£122,897.78
May '11	Lord Glendonbrook	Novartis / NYQ:NVS	£54.04	£115.96	114.58%	£150,203.87
Apr '23	Lord Grabiner	Novartis / NYQ:NVS	£95.80	£107.52	12.23%	£78,563.67**
Oct '19	Lord Farmer	Centene / NYQ:CNC	£44.09	£72.71	64.91%	£115,438.87**
May '23	Lord Fink	Healthcare Group / LSE:SPI.L	£227.50	£208.00	-8.57%	£64,000.00
Jan '24	Lord Fink	Roche / EBS:ROG.SW	£251.85	£260.00	3.24%	£72,265.24
Apr '21	Lord Grabiner	Roche / EBS:ROG.SW	£309.65	£260.00	-16.03%	£58,776.04
Apr '17	Lord Leigh of Hurley	Roche / EBS:ROG.SW	£255.80	£260.00	1.64%	£71,149.33
Aug '20	Lord Reay	Roche / EBS:ROG.SW	£315.05	£249.80	-20.71%	£55,502.30**
Feb '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£285.70	£272.40	-4.66%	£66,741.33**
Mar '25	Lord Fink	Roche / EBS:ROG.SW	£303.00	£260.00	-14.19%	£60,066.01
May '11	Lord Glendonbrook	Abbott Laboratories / NYQ:ABT	£25.27	£132.41	424.06%	£366,840.89
May '23	Lord Londesborough	Abbott Laboratories / NYQ:ABT	£108.82	£132.41	21.68%	£85,174.60
Jan '13	Lord Sassoon	Abbott Laboratories / NYQ:ABT	£32.90	£132.41	302.46%	£281,723.39
May '11	Lord Glendonbrook	Mesoblast / NMS:MESO	£101.20	£11.69	-88.45%	£8,085.97
May '11	Lord Glendonbrook	Pfizer / NYQ:PFE	£19.54	£23.88	22.18%	£85,527.49
Feb '16	Lord Lloyd-Webber	Pfizer / NYQ:PFE	£29.02	£23.88	-17.72%	£57,596.15
May '11	Lord Glendonbrook	Smith & Nephew / NYQ:SNN	£22.61	£28.58	26.43%	£88,502.38
Apr '10	Baroness Noakes	Smith & Nephew / NYQ:SNN	£20.98	£28.58	36.22%	£95,355.70
Jan '13	Lord Glendonbrook	Waters / NYQ:WAT	£87.09	£339.36	289.67%	£272,766.10
Oct '13	Lord Glendonbrook	Stryker / NYQ:SYK	£69.42	£373.26	437.68%	£376,378.59
Nov '23	Lord Mance	Stryker / NYQ:SYK	£275.00	£373.26	35.73%	£95,011.64
Mar '14	Lord Glendonbrook	Bb Biotech / EBS:BION.SW	£33.36	£27.20	-18.47%	£57,074.34**
Jun '16	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£47.80	£29.85	-37.55%	£43,713.39
Mar '17	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£54.95	£29.85	-45.68%	£38,025.48
Oct '20	Lord Glendonbrook	Bds / NGM:BDSX	£12.81	£0.28	-97.84%	£1,509.29
May '15	Lord Glendonbrook	Medtronic / NYQ:MDT	£78.41	£86.77	10.66%	£77,463.33**
Jan '18	Lord Glendonbrook	Cvs Health / NYQ:CVS	£79.44	£66.84	-15.86%	£58,897.28
Feb '13	Lord Nash	Cvs Health / NYQ:CVS	£52.66	£66.84	26.93%	£88,849.22
Jul '18	Lord Glendonbrook	Bayer / GER:BAYN.DE	£95.26	£26.93	-71.73%	£19,789.00
Jun '19	Lord Glendonbrook	Alcon / NYQ:ALC	£59.11	£80.92	36.90%	£95,828.11**
Dec '19	Lord Glendonbrook	Align Technology / NMS:ALGN	£273.75	£180.01	-34.24%	£46,029.95
May '24	Lord Goldsmith	Abbvie / NYQ:ABBV	£160.81	£185.49	15.35%	£80,743.12
Apr '21	Lord Grabiner	Boston Scientific / NYQ:BSX	£39.32	£93.67	138.22%	£166,757.37**
Apr '22	Lord Grabiner	Intuitive Surgical / NMS:ISRG	£277.85	£509.49	83.37%	£128,358.10
Jan '22	Lord Green of Hurstpierpoint	Intuitive Surgical / NMS:ISRG	£284.18	£529.42	86.30%	£130,408.19**
Nov '21	Lord Sherbourne of Didsbury	Intuitive Surgical / NMS:ISRG	£350.79	£509.49	45.24%	£101,668.52
Oct '15	Lord Hayward	Sage / NGM:SAGE	£46.11	£9.13	-80.20%	£13,860.33
Dec '22	Lord Hintze	Atai Life Sciences / NGM:ATAI	£3.48	£2.33	-33.05%	£46,867.81
Dec '22	Lord Hintze	Affimed / NGM:AFMD	£21.20	£0.08	-99.64%	£251.27
Mar '11	Lord Hollick	HCA / NYQ:HCA	£31.02	£376.86	1,114.89%	£850,425.50
Nov '17	Lord Howard of Rising	Ekf Diagnostics / LSE:EKF.L	£25.01	£26.30	5.16%	£73,609.96
Apr '22	Lord Hylton	Genus / LSE:GNS.L	£2,678.00	£1,940.00	-27.56%	£50,709.48
Jan '24	Lord Kakkar	Cyte / NMS:CTKB	£8.31	£3.71	-55.35%	£31,251.50**
Apr '10	Lord Lloyd-Webber	Idexx Labs / NMS:IDXX	£29.96	£519.85	1,635.15%	£1,214,602.79
Aug '16	Lord Lloyd-Webber	Eli Lilly / NYQ:LLY	£80.55	£67.15	-16.64%	£58,355.06**
Apr '24	Lord Mendoza	Eli Lilly / NYQ:LLY	£731.33	£785.03	7.34%	£75,139.95
Mar '17	Lord Lloyd-Webber	Hikma Pharmaceuticals / LSE:HIK.L	£2,026.00	£2,056.00	1.48%	£71,036.53
Sep '21	Lord Londesborough	Definitive Healthcare / NMS:DH	£43.29	£3.80	-91.22%	£6,144.61
Jul '21	Lord Londesborough	Goodrx / NMS:GDRX	£32.52	£4.48	-86.22%	£9,643.30
Nov '23	Lord Mance	Eli Lilly Co / VIE:LLYC.VI	£557.00	£677.90	21.71%	£85,193.90
Mar '24	Lord Moynihan of Chelsea	Candel Therapeutics / NGM:CADL	£1.40	£4.92	251.43%	£246,000.00
Mar '24	Lord Moynihan of Chelsea	Journey Medical / NCM:DERM	£3.74	£6.35	69.79%	£118,850.27
Mar '24	Lord Moynihan of Chelsea	Evotec / NMS:EVO	£7.13	£3.97	-44.32%	£38,976.16
Mar '24	Lord Moynihan of Chelsea	Fortress Biotech / NCM:FBIO	£1.92	£1.81	-5.73%	£65,989.58
Mar '24	Lord Moynihan of Chelsea	Mustang Bio / NCM:MBIO	£1.04	£1.07	2.88%	£72,019.23
Mar '24	Lord Moynihan of Chelsea	Tg Therapeutics / NCM:TGTX	£15.05	£35.17	133.65%	£163,558.14
Mar '24	Lord Moynihan of Chelsea	Adaptimmune / NMS:ADAP	£1.47	£0.26	-82.59%	£12,190.48
Mar '24	Lord Moynihan of Chelsea	Avenue Therapeutics / NCM:ATXI	£12.00	£0.26	-97.84%	£1,513.75
Apr '19	Lord Nash	Eq / NCM:EQ	£8.20	£0.69	-91.59%	£5,890.24**
Aug '23	Lord Nash	Relay / NGM:RLAY	£10.62	£3.36	-68.36%	£22,146.89
Sep '23	Lord Nash	Abingdon / LSE:ABDX.L	£11.25	£7.00	-37.78%	£43,555.56
Mar '24	Lord Petitgas	Royalty Pharma / NMS:RPRX	£30.08	£34.91	16.06%	£81,240.03
Mar '24	Lord Petitgas	Moderna / NMS:MRNA	£111.98	£25.40	-77.32%	£15,877.83
May '23	Lord Reay	Sanofi / NMS:SNY	£55.11	£47.22	-14.32%	£59,978.23**
May '22	Lord Saatchi	Walgreen / NMS:WBA	£43.85	£11.39	-74.03%	£18,182.44
Jul '23	Lord Sassoon	Haleon / LSE:HLN.L	£336.10	£382.50	13.81%	£79,663.79
Mar '23	Baroness Shields	Benevolentai / AMS:BAI.AS	£2.46	£0.09	-96.14%	£2,703.25
Jan '21	Lord Spencer of Alresford	Immupharma / LSE:IMM.L	£12.65	£2.28	-81.98%	£12,616.60
May '23	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£180.80	£204.10	12.89%	£79,023.12**
Jun '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£208.20	£197.20	-5.28%	£66,301.63**
Aug '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£207.50	£240.30	15.81%	£81,065.06
Mar '25	Lord Fink	Essilorluxottica / PAR:EL.PA	£273.20	£240.30	-12.04%	£61,570.28
Jun '22	Lord Stevens of Ludgate	Verici Dx / LSE:VRCI.L	£26.00	£1.25	-95.19%	£3,365.38
May '23	Lord Stevens of Ludgate	Avacta Group / LSE:AVCT.L	£112.00	£30.50	-72.77%	£19,062.50
Jun '22	Lord Sugar	Acl / NMS:ACLX	£17.47	£63.82	265.31%	£255,718.39
May '22	Lord Triesman	Blue / NMS:BLUE	£3.39	£4.97	46.61%	£102,625.36
May '20	Lord Wolfson of Aspley Guise	Adc Therapeutics / NYQ:ADCT	£30.00	£3.03	-89.90%	£7,070.00
Nov '24	Lord Moynihan of Chelsea	Sab Biotherapeutics / NCM:SABS	£3.95	£1.78	-54.94%	£31,544.30

* Minimum Potential Value based on £70,000.00 invested at time of declaration.

** Interest ceased/exited on filed date.